{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:01:54Z","timestamp":1740106914383,"version":"3.37.3"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T00:00:00Z","timestamp":1722643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T00:00:00Z","timestamp":1722643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s00277-024-05913-7","type":"journal-article","created":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T06:02:00Z","timestamp":1722664920000},"page":"3443-3451","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Inpatient outcomes of NSTEMI among patients with immune thrombocytopenia: a propensity matched national study"],"prefix":"10.1007","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-8554-7980","authenticated-orcid":false,"given":"Mirza Faris Ali","family":"Baig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalyan","family":"Chaliki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,3]]},"reference":[{"issue":"3","key":"5913_CR1","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/s0735-1097(98)00635-4","volume":"33","author":"KA Ault","year":"1999","unstructured":"Ault KA, Cannon CP, Mitchell J et al (1999) Platelet activation in patients after an acute coronary syndrome: results from the TIMI-12 trial. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol. 33(3):634\u2013639. https:\/\/doi.org\/10.1016\/s0735-1097(98)00635-4","journal-title":"J Am Coll Cardiol."},{"issue":"15","key":"5913_CR2","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1093\/eurheartj\/eht438","volume":"35","author":"C Varenhorst","year":"2014","unstructured":"Varenhorst C, Jensevik K, Jernberg T et al (2014) Duration of dual antiplatelet treatment with clopidogrel and aspirin in patients with acute coronary syndrome. Eur Heart J 35(15):969\u2013978. https:\/\/doi.org\/10.1093\/eurheartj\/eht438","journal-title":"Eur Heart J"},{"key":"5913_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2147\/OAEM.S331675","volume":"14","author":"T Zitek","year":"2022","unstructured":"Zitek T, Weber L, Pinzon D, Warren N (2022) Assessment and Management of Immune Thrombocytopenia (ITP) in the emergency department: current perspectives. Open Access Emerg Med 14:25\u201334. https:\/\/doi.org\/10.2147\/OAEM.S331675","journal-title":"Open Access Emerg Med"},{"issue":"2","key":"5913_CR4","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1080\/13696998.2019.1669329","volume":"23","author":"D Weycker","year":"2020","unstructured":"Weycker D, Hanau A, Hatfield M et al (2020) Primary immune thrombocytopenia in US clinical practice: incidence and healthcare burden in first 12 months following diagnosis. J Med Econ 23(2):184\u2013192. https:\/\/doi.org\/10.1080\/13696998.2019.1669329","journal-title":"J Med Econ"},{"key":"5913_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.103820","volume":"76","author":"D Provan","year":"2022","unstructured":"Provan D, Semple JW (2022) Recent advances in the mechanisms and treatment of immune thrombocytopenia. EBioMedicine 76:103820. https:\/\/doi.org\/10.1016\/j.ebiom.2022.103820","journal-title":"EBioMedicine"},{"key":"5913_CR6","doi-asserted-by":"publisher","DOI":"10.1177\/20406207211010875","volume":"12","author":"N Cooper","year":"2021","unstructured":"Cooper N, Altomare I, Thomas MR et al (2021) Assessment of thrombotic risk during long-term treatment of immune thrombocytopenia with fostamatinib. Ther Adv Hematol 12:20406207211010875. https:\/\/doi.org\/10.1177\/20406207211010875","journal-title":"Ther Adv Hematol"},{"issue":"10","key":"5913_CR7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.30279","volume":"14","author":"EA Ali","year":"2022","unstructured":"Ali EA, Rasheed M, Al-Sadi A, Awadelkarim AM, Saad EA, Yassin MA (2022) Immune thrombocytopenic purpura and paradoxical thrombosis: a systematic review of case reports. Cureus 14(10):e30279. https:\/\/doi.org\/10.7759\/cureus.30279","journal-title":"Cureus"},{"key":"5913_CR8","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12872-015-0092-3","volume":"15","author":"G Li-Sha","year":"2015","unstructured":"Li-Sha G, Peng C, Yue-Chun L (2015) Recurrent acute coronary syndrome and restenosis after percutaneous coronary intervention in a patient with idiopathic thrombocytopenic purpura: a case report and literature review. BMC Cardiovasc Disord 15:101. https:\/\/doi.org\/10.1186\/s12872-015-0092-3","journal-title":"BMC Cardiovasc Disord"},{"key":"5913_CR9","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1182\/asheducation-2015.1.237","volume":"2015","author":"DM Arnold","year":"2015","unstructured":"Arnold DM (2015) Bleeding complications in immune thrombocytopenia. Hematology Am Soc Hematol Educ Program 2015:237\u2013242. https:\/\/doi.org\/10.1182\/asheducation-2015.1.237","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"1","key":"5913_CR10","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13045-023-01401-z","volume":"16","author":"XG Liu","year":"2023","unstructured":"Liu XG, Hou Y, Hou M (2023) How we treat primary immune thrombocytopenia in adults. J Hematol Oncol 16(1):4. https:\/\/doi.org\/10.1186\/s13045-023-01401-z","journal-title":"J Hematol Oncol"},{"issue":"1","key":"5913_CR11","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/clc.23287","volume":"43","author":"O Chehab","year":"2020","unstructured":"Chehab O, Abdallah N, Kanj A et al (2020) Impact of immune thrombocytopenic purpura on clinical outcomes in patients with acute myocardial infarction. Clin Cardiol 43(1):50\u201359. https:\/\/doi.org\/10.1002\/clc.23287","journal-title":"Clin Cardiol"},{"issue":"47","key":"5913_CR12","doi-asserted-by":"publisher","first-page":"3488","DOI":"10.1093\/eurheartj\/ehx531","volume":"38","author":"CP McCarthy","year":"2017","unstructured":"McCarthy CP, Steg G, Bhatt DL (2017) The management of antiplatelet therapy in acute coronary syndrome patients with thrombocytopenia: a clinical conundrum. Eur Heart J 38(47):3488\u20133492. https:\/\/doi.org\/10.1093\/eurheartj\/ehx531","journal-title":"Eur Heart J"},{"key":"5913_CR13","unstructured":"HCUP National Inpatient Sample (NIS). Healthcare Cost and Utilization Project (HCUP) (2019) Agency for healthcare research and quality, Rockville. www.hcup-us.ahrq.gov\/nisoverview.jsp.\u00a0 Accessed Mar 2024"},{"key":"5913_CR14","doi-asserted-by":"publisher","DOI":"10.1155\/2009\/963506","volume":"2009","author":"MA Feudjo-Tepie","year":"2009","unstructured":"Feudjo-Tepie MA, Le Roux G, Beach KJ, Bennett D, Robinson NJ (2009) Comorbidities of idiopathic thrombocytopenic purpura: a population-based study. Adv Hematol 2009:963506. https:\/\/doi.org\/10.1155\/2009\/963506","journal-title":"Adv Hematol"},{"issue":"4","key":"5913_CR15","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/s0828-282x(10)70371-8","volume":"26","author":"P Puddu","year":"2010","unstructured":"Puddu P, Puddu GM, Cravero E, Muscari S, Muscari A (2010) The involvement of circulating microparticles in inflammation, coagulation and cardiovascular diseases. Can J Cardiol 26(4):140\u2013145. https:\/\/doi.org\/10.1016\/s0828-282x(10)70371-8","journal-title":"Can J Cardiol"},{"key":"5913_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2022.103581","volume":"171","author":"M Tjepkema","year":"2022","unstructured":"Tjepkema M, Amini S, Schipperus M (2022) Risk of thrombosis with thrombopoietin receptor agonists for ITP patients: a systematic review and meta-analysis. Crit Rev Oncol Hematol 171:103581. https:\/\/doi.org\/10.1016\/j.critrevonc.2022.103581","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"5913_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpth.2024.102342","volume":"8","author":"I Goncalves","year":"2024","unstructured":"Goncalves I, Lewis C, Grainger B et al (2024) Thrombosis in patients with immune thrombocytopenia: incidence, risk, and clinical outcomes. Res Pract Thromb Haemost 8(1):102342. https:\/\/doi.org\/10.1016\/j.rpth.2024.102342","journal-title":"Res Pract Thromb Haemost"},{"issue":"8","key":"5913_CR18","doi-asserted-by":"publisher","first-page":"MC01","DOI":"10.7860\/JCDR\/2014\/8394.4650","volume":"8","author":"R Pal","year":"2014","unstructured":"Pal R, Bagarhatta R, Gulati S, Rathore M, Sharma N (2014) Mean platelet volume in patients with acute coronary syndromes: a supportive diagnostic predictor. J Clin Diagn Res 8(8):MC01-MC4. https:\/\/doi.org\/10.7860\/JCDR\/2014\/8394.4650","journal-title":"J Clin Diagn Res"},{"issue":"2","key":"5913_CR19","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.amjms.2016.04.014","volume":"352","author":"X Wang","year":"2016","unstructured":"Wang X, Xu XL, Li XM, Zhao R, Yang X, Cong HL (2016) Diagnostic value of mean platelet volume combined with troponin i for acute coronary syndrome. Am J Med Sci 352(2):159\u2013165. https:\/\/doi.org\/10.1016\/j.amjms.2016.04.014","journal-title":"Am J Med Sci"},{"issue":"1","key":"5913_CR20","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12872-019-1115-2","volume":"19","author":"J Wang","year":"2019","unstructured":"Wang J, Li X, Pu J et al (2019) Mean platelet volume and coronary plaque vulnerability: an optical coherence tomography study in patients with non-ST-elevation acute coronary syndrome. BMC Cardiovasc Disord 19(1):128. https:\/\/doi.org\/10.1186\/s12872-019-1115-2","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"5913_CR21","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2174\/138161211795049804","volume":"17","author":"AY Gasparyan","year":"2011","unstructured":"Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD (2011) Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des 17(1):47\u201358. https:\/\/doi.org\/10.2174\/138161211795049804","journal-title":"Curr Pharm Des"},{"key":"5913_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.770436","volume":"12","author":"B Tokarz-Deptu\u0142a","year":"2021","unstructured":"Tokarz-Deptu\u0142a B, Palma J, Baraniecki \u0141, Stosik M, Ko\u0142acz R, Deptu\u0142a W (2021) What function do platelets play in inflammation and bacterial and viral infections? Front Immunol 12:770436. https:\/\/doi.org\/10.3389\/fimmu.2021.770436","journal-title":"Front Immunol"},{"issue":"12","key":"5913_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2022-253140","volume":"15","author":"MU Shah","year":"2022","unstructured":"Shah MU, Muhammad A, Davison B, Naqvi SY (2022) Invasive management of non-ST elevation myocardial infarction (NSTEMI) in a patient with severe thrombocytopenia secondary to adult-onset immune thrombocytopenic purpura. BMJ Case Rep 15(12):e253140. https:\/\/doi.org\/10.1136\/bcr-2022-253140","journal-title":"BMJ Case Rep"},{"issue":"9","key":"5913_CR24","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/S1726-4901(09)70287-4","volume":"69","author":"MC Fong","year":"2006","unstructured":"Fong MC, Chen KC, Leu HB, Chen LC (2006) Coronary revascularization in a patient with immune thrombocytopenic purpura. J Chin Med Assoc 69(9):436\u2013438. https:\/\/doi.org\/10.1016\/S1726-4901(09)70287-4","journal-title":"J Chin Med Assoc"},{"issue":"2","key":"5913_CR25","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1253\/jcj.63.133","volume":"63","author":"T Fuchi","year":"1999","unstructured":"Fuchi T, Kondo T, Sase K, Takahashi M (1999) Primary percutaneous transluminal coronary angioplasty performed for acute myocardial infarction in a patient with idiopathic thrombocytopenic purpura. Jpn Circ J 63(2):133\u2013136. https:\/\/doi.org\/10.1253\/jcj.63.133","journal-title":"Jpn Circ J"},{"key":"5913_CR26","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/174659","volume":"2013","author":"E Torbey","year":"2013","unstructured":"Torbey E, Yacoub H, McCord D, Lafferty J (2013) Two cases and review of the literature: primary percutaneous angiography and antiplatelet management in patients with immune thrombocytopenic purpura. ISRN Hematol 2013:174659. https:\/\/doi.org\/10.1155\/2013\/174659","journal-title":"ISRN Hematol"},{"key":"5913_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1213275","volume":"10","author":"A Rahhal","year":"2023","unstructured":"Rahhal A, Provan D, Shunnar K et al (2023) Concurrent coronary artery disease and immune thrombocytopenia: a systematic review. Front Med (Lausanne) 10:1213275. https:\/\/doi.org\/10.3389\/fmed.2023.1213275","journal-title":"Front Med (Lausanne)"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05913-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-024-05913-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-05913-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T09:19:36Z","timestamp":1724836776000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-024-05913-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,3]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["5913"],"URL":"https:\/\/doi.org\/10.1007\/s00277-024-05913-7","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2024,8,3]]},"assertion":[{"value":"20 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research study was conducted retrospectively from data obtained for clinical purposes. We purchased the de-identified data from the Agency for Healthcare Research and Quality (AHRQ). Since no patient-level information is identifiable, the study was exempt from IRB approval","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}